Pediatric and Primary Lymphedema (PPL-WG)
Clinical Expert Consensus Statements Written
The Pediatric and Primary Lymphedema Working Group (PPL-WG) have developed consensus statements drawing from the latest research and clinical data to provide evidence-based recommendations for the diagnosis, treatment and management of these diseases.
The PPL-WG is currently working on the production of consensus statement documents on various topics including diagnostic patient pathway for PPL, QoL for children, compression in children.
Results (4)
Consensus recommendations on lymphedema in Phelan-McDermid syndrome
April 17 2023
COVID-19 (Coronavirus) Richtlinien für die Gemeinschaft der Lymphgefäßkrankheiten
March 30 2023
The Pediatric and Primary Lymphedema (PPL) Working Group endorses the COVID-19 statement by the Lymphoedema Support Network
VASCERN Pediatric and Primary Lymphedema (PPL) Working Group – Statement concerning SARS-CoV-2 vaccination for patients with lymphedema
March 09 2023
COVID-19 statement by the Lymphoedema Support Network
March 09 2023
The Pediatric and Primary Lymphedema (PPL) Working Group endorses the COVID-19 statement by the Lymphoedema Support Network.